EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study

Derya Sema Yaman Kalender iD, Mehmet Eren Kalender, Nermin Topaloğlu iD

Photobiomodulation, Photomedicine, and Laser Surgery · 2026

DOI: 10.1177/25785478261486643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Photobiomodulation, Photomedicine, and Laser Surgery, 2026. Verfasst von Derya Sema Yaman Kalender und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Technologies, Institute of Natural and Applied Sciences, Izmir Katip Celebi University, Izmir, Türkiye. Hauptthemen laut MEDLINE: Photochemotherapy, Indocyanine Green, Pioglitazone, Thyroid Neoplasms. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Türkiye Sağlık Enstitüleri Başkanlığı.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Among thyroid malignancies, papillary thyroid carcinoma (PTC) occurs most frequently, and therapeutic resistance remains a major obstacle in advanced disease. In this study, we evaluated the potential of pioglitazone (PIO), a peroxisome proliferator-activated receptor gamma agonist, to enhance the efficacy of indocyanine green (ICG)-mediated photodynamic therapy (PDT) in B-CPAP human PTC cells.

Methods

After dose optimization, PIO and ICG were tested individually and in combination with laser irradiation (808 nm, 50 J/cm 2 ). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was utilized to assess cell viability, while intracellular reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP) were examined to better elucidate the underlying mechanisms.

Results

PIO alone showed minimal cytotoxicity in B-CPAP cells, whereas ICG–PDT induced a moderate reduction in viability. The combined treatment with 64.5 μM ICG and 509.0 μM PIO under PDT conditions significantly decreased cell survival to ∼50%, resulting in a substantial elevation in ROS levels and disruption of MMP. Importantly, this combination also exhibited cytotoxic effects in a non-malignant thyroid epithelial cell line (Nthy-ori 3-1), though to a lesser extent.

Conclusions

These findings demonstrate that PIO potentiates the antitumor activity of ICG–PDT by inducing oxidative stress and mitochondrial dysfunction. This in vitro approach suggests a rational, combinatorial strategy that merits further investigation in preclinical models of thyroid cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyIndocyanine GreenPioglitazoneThyroid NeoplasmsThyroid Cancer, PapillaryPhotosensitizing AgentsHumansCell SurvivalCell Line, TumorReactive Oxygen SpeciesPPAR-gamma AgonistsMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

indocyanine greenphotodynamic therapypioglitazonethyroid cancer

Substanzen

Indocyanine GreenPioglitazoneReactive Oxygen SpeciesPPAR-gamma AgonistsPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Biomedical Technologies, Institute of Natural and Applied Sciences, Izmir Katip Celebi University, Izmir, Türkiye.
  • Department of Endocrinology and Metabolism, Atatürk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Türkiye.
  • Department of Medical Oncology, Atatürk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Türkiye.
  • Department of Biomedical Engineering, Faculty of Engineering and Architecture, Izmir Katip Celebi University, Izmir, Türkiye.

ORCID-Profile: Derya Sema Yaman Kalender, Nermin Topaloğlu

Förderung

  • Türkiye Sağlık Enstitüleri Başkanlığı

Zitieren

APA

Yaman Kalender, D. S., Kalender, M. E., & Topaloğlu, N. (2026). Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study. Photobiomodulation, Photomedicine, and Laser Surgery. https://doi.org/10.1177/25785478261486643

Vancouver

Yaman Kalender DS, Kalender ME, Topaloğlu N. Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study. Photobiomodulation, Photomedicine, and Laser Surgery. 2026. doi:10.1177/25785478261486643

BibTeX
@article{YamanKalender2026,
  author = {Yaman Kalender, Derya Sema and Kalender, Mehmet Eren and Topaloğlu, Nermin},
  title = {Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study},
  journal = {Photobiomodulation, Photomedicine, and Laser Surgery},
  year = {2026},
  doi = {10.1177/25785478261486643}
}
Kostenlos starten →